1. Home
  2. PEN vs IONQ Comparison

PEN vs IONQ Comparison

Compare PEN & IONQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • IONQ
  • Stock Information
  • Founded
  • PEN 2004
  • IONQ 2015
  • Country
  • PEN United States
  • IONQ United States
  • Employees
  • PEN N/A
  • IONQ N/A
  • Industry
  • PEN Medical/Dental Instruments
  • IONQ Wholesale Distributors
  • Sector
  • PEN Health Care
  • IONQ Industrials
  • Exchange
  • PEN Nasdaq
  • IONQ Nasdaq
  • Market Cap
  • PEN 10.0B
  • IONQ 8.5B
  • IPO Year
  • PEN 2015
  • IONQ N/A
  • Fundamental
  • Price
  • PEN $291.61
  • IONQ $31.74
  • Analyst Decision
  • PEN Buy
  • IONQ Strong Buy
  • Analyst Count
  • PEN 16
  • IONQ 5
  • Target Price
  • PEN $287.07
  • IONQ $33.00
  • AVG Volume (30 Days)
  • PEN 509.6K
  • IONQ 15.3M
  • Earning Date
  • PEN 02-18-2025
  • IONQ 02-26-2025
  • Dividend Yield
  • PEN N/A
  • IONQ N/A
  • EPS Growth
  • PEN N/A
  • IONQ N/A
  • EPS
  • PEN 0.36
  • IONQ N/A
  • Revenue
  • PEN $1,194,615,000.00
  • IONQ $37,469,000.00
  • Revenue This Year
  • PEN $13.65
  • IONQ $92.71
  • Revenue Next Year
  • PEN $14.30
  • IONQ $100.39
  • P/E Ratio
  • PEN $811.72
  • IONQ N/A
  • Revenue Growth
  • PEN 12.86
  • IONQ 89.78
  • 52 Week Low
  • PEN $148.00
  • IONQ $6.22
  • 52 Week High
  • PEN $310.00
  • IONQ $54.74
  • Technical
  • Relative Strength Index (RSI)
  • PEN 65.03
  • IONQ 36.77
  • Support Level
  • PEN $264.82
  • IONQ $32.34
  • Resistance Level
  • PEN $310.00
  • IONQ $44.34
  • Average True Range (ATR)
  • PEN 7.93
  • IONQ 3.45
  • MACD
  • PEN 2.79
  • IONQ -0.99
  • Stochastic Oscillator
  • PEN 64.07
  • IONQ 2.80

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.

About IONQ IonQ Inc.

IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems, and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.

Share on Social Networks: